Released Aug 5, 2022, before the open
10-Q filed Aug 5, 2022, 36 days after period end · 0000950170-22-014951
Q2 2022 · 10-Q
Revenue$118.07M$118.07M −2.7% vs Q2 2021+10.9% vs Q1 2022
Net Income$2.49M$2.49M +2.9% vs Q2 2021N/M vs Q1 2022
EPS Diluted$0.12$0.12 ±0.0% vs Q2 2021N/M vs Q1 2022
Gross Profit$86,470,000−8.0%
Operating Income$6,641,000+55.6%
Operating Cash Flowderived-$4,913,000N/M
Free Cash Flowderived-$10,616,000N/M
Margins · derived
Gross margin73.2%−4.2 pt vs Q2 2021
Operating margin5.6%+2.1 pt vs Q2 2021
Net margin2.1%+0.1 pt vs Q2 2021
What the release said
The release
Same quarter
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $118.07M | $121.39M | $73.14M | $115.85M |
| Net Income | $2.49M | $2.42M | -$18.42M | -$547.00K |
| EPS Diluted | $0.12 | $0.12 | -$0.96 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR